NeuroTherapia, Inc.
Categories
PharmaceuticalsDescription
Gates Mills, OH 44040-7451
NeuroTherapia, Inc., founded in 2015 by Cleveland Clinic Innovations based on research by Drs. Mohamed Naguib and Joseph Foss, on new therapies for diseases with an underlying component of neuroinflammation. Initial research has led to the development of our lead compound NTRX-07. NTRX-07 (previously known as MDA7) has been shown to decrease activation of microglial cells in the brain. Decreasing activation of these cells leads to decreased inflammation and decreased injury to surrounding nerve cells. Decreasing this inflammation can treat and even prevent the development of neuropathic pain in settings of nerve injury or chemotherapy. Recent work has shown that blocking this inflammation is also important in reversing the effects seen in Alzheimer's disease.
Business Overview
Directions to listing
Disclaimer
The Ohio Life Sciences Directory is provided by Ohio Life Sciences for the purpose of promoting life sciences-related organizations in Ohio. Profiles are based on publicly available and company-provided information. Ohio Life Sciences is a member supported organization, therefore members are prioritized in search results and receive special logo visibility, but non-members are included. Members may request a targeted, staff-generated offline search of the Directory. Ohio Life Sciences works to keep the Directory up to date, however, as details may change without notice, users should always refer to the listed organization directly for current information. Placement of a Directory listing does not represent an endorsement or testimony from Ohio Life Sciences as to the quality/validity of the products/services listed. Ohio Life Sciences retains exclusive management of OhioLifeSciences.org content and reserves the right to accept, reject, or remove listings on the Ohio Life Sciences website at any time. Questions? Want to update or list your organization? Please visit our contact page.